Muscle profiles Different skeletal myofibre types are known to express distinct muscle myosin isoforms. In the Early Edition of the Proceedings of the National Academy of Sciences, Porter et al., from ...

The loss of muscle mass and strength poses an increasingly significant challenge for an aging society. Prof. Kristina ...

Cars with muscle will be on vroom-vroom view at this free car show The Original Farmers Market will jumpstart June with a popular tradition: A display of vintage vehicles.

Unlock serious lower body power by training the muscle group most lifters ignore. Add these adductor movements to your routine to build strength, prevent injury, and level up performance with the Mast ...

Protein bars, shakes and pre-workout mixes are often used to maximize results at the gym. The supplements are also associated with muscle dysmorphia, a study shows.

Recent studies have found that Ozempic could lead to more muscle mass loss than traditional weight loss methods.

Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share how clinicians can prevent the problem and what interventions can help.

Taking protein powder or creatine after a workout may aid in muscle recovery and exercise performance. Learn more.

Aside from people using GLP-1s, a loss of muscle mass is a significant concern for aging patients as well. ProFuse Technology is a company focused on the development of muscle tissue in laboratory ...

NEW ORLEANS — Medications in development would preserve muscle mass and augment fat loss when used in combination with glucagon-like peptide 1 (GLP-1) receptor agonists taken for weight loss.

Drugs like Wegovy and Zepbound lead to both fat and muscle loss. An updated STAT Obesity Drug Tracker shows that some companies are testing drugs that preserve or grow muscle while reducing fat.

Companies are investigating ways to prevent people from losing muscle when on popular weight-loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.